Fw: Life Extension Update March 20, 2012
Life Extension UpdateOmega-3 fatty acids reduce cardiovascular events in non-statin
drug users
Tuesday, March 20, 2012. An article published on February 1, 2012 in advance
of print in the European Heart Journal reports a favorable effect for low dose
omega-3 fatty acids on the risk of cardiovascular events, including heart attack,
cardiac arrest and stroke, in patients with a history of heart attack who did
not use statin drugs.
The current study included 3,740 men and women using statin drugs and 413 non-users
who participated in the Alpha Omega Trial, which tested the effects of 400 milligrams
per day of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic
acid (DHA), 2 grams per day of the omega-3 fatty acid alpha-linolenic acid (ALA),
EPA/DHA plus alpha-linolenic acid, or a placebo on the risk of major cardiovascular
events in post-heart attack patients between the ages of 60 and 80 years. Participants
were enrolled from 2002 through 2006 and were followed for an average of 41 months.
